LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | Mitoxantrone | 0.12 | uM | LJP5 | 3 | C23 | 72 | hr | 2543 | 1931 | 5760 | 0.3352 | -0.2083 |
SK-BR-3 | Mitoxantrone | 0.37 | uM | LJP6 | 1 | C22 | 72 | hr | 2543 | 1390 | 5258 | 0.2643 | -0.4382 |
SK-BR-3 | Mitoxantrone | 0.37 | uM | LJP6 | 2 | C22 | 72 | hr | 2543 | 1415 | 5438 | 0.2602 | -0.4143 |
SK-BR-3 | Mitoxantrone | 0.37 | uM | LJP6 | 3 | C22 | 72 | hr | 2543 | 1408 | 5557 | 0.2534 | -0.4081 |
SK-BR-3 | Mitoxantrone | 0.37 | uM | LJP5 | 1 | C22 | 72 | hr | 2543 | 1727 | 5734 | 0.3012 | -0.2811 |
SK-BR-3 | Mitoxantrone | 0.37 | uM | LJP5 | 2 | C22 | 72 | hr | 2543 | 1720 | 5761 | 0.2985 | -0.2823 |
SK-BR-3 | Mitoxantrone | 0.37 | uM | LJP5 | 3 | C22 | 72 | hr | 2543 | 1906 | 5760 | 0.3309 | -0.2170 |
SK-BR-3 | Mitoxantrone | 1.11 | uM | LJP6 | 1 | C21 | 72 | hr | 2543 | 1357 | 5258 | 0.2580 | -0.4509 |
SK-BR-3 | Mitoxantrone | 1.11 | uM | LJP6 | 2 | C21 | 72 | hr | 2543 | 1362 | 5438 | 0.2505 | -0.4343 |
SK-BR-3 | Mitoxantrone | 1.11 | uM | LJP6 | 3 | C21 | 72 | hr | 2543 | 1380 | 5557 | 0.2483 | -0.4186 |
SK-BR-3 | Mitoxantrone | 1.11 | uM | LJP5 | 1 | C21 | 72 | hr | 2543 | 1709 | 5734 | 0.2980 | -0.2875 |
SK-BR-3 | Mitoxantrone | 1.11 | uM | LJP5 | 2 | C21 | 72 | hr | 2543 | 1595 | 5761 | 0.2768 | -0.3267 |
SK-BR-3 | Mitoxantrone | 1.11 | uM | LJP5 | 3 | C21 | 72 | hr | 2543 | 1796 | 5760 | 0.3118 | -0.2555 |
SK-BR-3 | Mitoxantrone | 3.33 | uM | LJP6 | 1 | C20 | 72 | hr | 2543 | 910 | 5258 | 0.1730 | -0.6250 |
SK-BR-3 | Mitoxantrone | 3.33 | uM | LJP6 | 2 | C20 | 72 | hr | 2543 | 1108 | 5438 | 0.2038 | -0.5314 |
SK-BR-3 | Mitoxantrone | 3.33 | uM | LJP6 | 3 | C20 | 72 | hr | 2543 | 1111 | 5557 | 0.1999 | -0.5203 |
SK-BR-3 | Mitoxantrone | 3.33 | uM | LJP5 | 1 | C20 | 72 | hr | 2543 | 1217 | 5734 | 0.2122 | -0.4666 |
SK-BR-3 | Mitoxantrone | 3.33 | uM | LJP5 | 2 | C20 | 72 | hr | 2543 | 1253 | 5761 | 0.2175 | -0.4513 |
SK-BR-3 | Mitoxantrone | 3.33 | uM | LJP5 | 3 | C20 | 72 | hr | 2543 | 1456 | 5760 | 0.2527 | -0.3768 |
SK-BR-3 | Mitoxantrone | 10 | uM | LJP6 | 1 | C19 | 72 | hr | 2543 | 298 | 5258 | 0.0567 | -0.8708 |
SK-BR-3 | Mitoxantrone | 10 | uM | LJP6 | 2 | C19 | 72 | hr | 2543 | 348 | 5438 | 0.0640 | -0.8371 |
SK-BR-3 | Mitoxantrone | 10 | uM | LJP6 | 3 | C19 | 72 | hr | 2543 | 239 | 5557 | 0.0430 | -0.8772 |
SK-BR-3 | Mitoxantrone | 10 | uM | LJP5 | 1 | C19 | 72 | hr | 2543 | 423 | 5734 | 0.0738 | -0.7834 |
SK-BR-3 | Mitoxantrone | 10 | uM | LJP5 | 2 | C19 | 72 | hr | 2543 | 479 | 5761 | 0.0831 | -0.7572 |
SK-BR-3 | Mitoxantrone | 10 | uM | LJP5 | 3 | C19 | 72 | hr | 2543 | 582 | 5760 | 0.1010 | -0.7136 |